9-127612401-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_003165.6(STXBP1):c.-3G>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000107 in 1,595,014 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000040 ( 0 hom., cov: 30)
Exomes 𝑓: 0.0000076 ( 0 hom. )
Consequence
STXBP1
NM_003165.6 5_prime_UTR
NM_003165.6 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0410
Genes affected
STXBP1 (HGNC:11444): (syntaxin binding protein 1) This gene encodes a syntaxin-binding protein. The encoded protein appears to play a role in release of neurotransmitters via regulation of syntaxin, a transmembrane attachment protein receptor. Mutations in this gene have been associated with infantile epileptic encephalopathy-4. Alternatively spliced transcript variants have been described. [provided by RefSeq, Feb 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 9-127612401-G-T is Benign according to our data. Variant chr9-127612401-G-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 1193036.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}.
BS2
High AC in GnomAd4 at 6 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
STXBP1 | NM_001032221.6 | c.-3G>T | 5_prime_UTR_variant | 1/19 | ENST00000373299.5 | ||
STXBP1 | NM_003165.6 | c.-3G>T | 5_prime_UTR_variant | 1/20 | ENST00000373302.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
STXBP1 | ENST00000373299.5 | c.-3G>T | 5_prime_UTR_variant | 1/19 | 1 | NM_001032221.6 | A1 | ||
STXBP1 | ENST00000373302.8 | c.-3G>T | 5_prime_UTR_variant | 1/20 | 1 | NM_003165.6 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151838Hom.: 0 Cov.: 30
GnomAD3 genomes
AF:
AC:
6
AN:
151838
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000178 AC: 4AN: 225232Hom.: 0 AF XY: 0.00000808 AC XY: 1AN XY: 123736
GnomAD3 exomes
AF:
AC:
4
AN:
225232
Hom.:
AF XY:
AC XY:
1
AN XY:
123736
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000762 AC: 11AN: 1443176Hom.: 0 Cov.: 31 AF XY: 0.00000697 AC XY: 5AN XY: 717680
GnomAD4 exome
AF:
AC:
11
AN:
1443176
Hom.:
Cov.:
31
AF XY:
AC XY:
5
AN XY:
717680
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151838Hom.: 0 Cov.: 30 AF XY: 0.0000270 AC XY: 2AN XY: 74146
GnomAD4 genome
AF:
AC:
6
AN:
151838
Hom.:
Cov.:
30
AF XY:
AC XY:
2
AN XY:
74146
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 06, 2017 | The c.-3G>T variant is located in the 5' untranslated region (5’ UTR) of the STXBP1 gene. This variant results from a G to T substitution 3 bases upstream from the first translated codon. This nucleotide position is highly conserved in available vertebrate species. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 11, 2019 | Has not been previously published as pathogenic or benign to our knowledge; Regulatory variants have not been reported in the Human Gene Mutation Database in individuals with STXBP1-related disorders (Stenson et al., 2014) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at